Top Sell
Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Carisma Therapeutics Inc. | 0 | 1 | 0 | 1 | €1.29 | - | - |
Akebia Therapeutics Inc. | 7 | 3 | 0 | 1 | €0.87 | €3.60 | 312.741% |
Cara Therapeutics Inc. | 11 | 6 | 0 | 1 | €0.25 | €4.61 | 1719.510% |
Ardelyx Inc. | 3 | 1 | 2 | 1 | €4.89 | €11.00 | 124.857% |
Sangamo Therapeutics Inc. | 12 | 13 | 0 | 1 | €0.32 | €3.63 | 1041.976% |
Trevena Inc. | 3 | 19 | 0 | 1 | €0.14 | €4.60 | 3079.461% |
Moleculin Biotech Inc | 3 | 24 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.25 | €7.35 | 2811.525% |
Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.49 | - | - |
Ironwood Pharmaceuticals | 8 | 1 | 0 | 0 | €5.75 | €18.80 | 226.906% |
Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.75 | - | - |
Chimerix Inc. | 3 | 1 | 0 | 0 | €0.80 | €5.51 | 587.606% |
Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 950.465% |
Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.71 | - | - |
Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.04 | €7.31 | 140.395% |
Neptune Wellness Solutions Inc | 0 | 11 | 0 | 0 | €0.14 | - | - |
Mirati Therapeutics Inc. | 2 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
Revance Therapeutics Inc. | 0 | 2 | 0 | 0 | €2.50 | - | - |
Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €5.10 | - | - |
Karyopharm Therapeutics Inc. | 10 | 2 | 1 | 0 | €0.77 | €6.95 | 805.221% |
BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.50 | - | - |
Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.05 | €58.50 | 729.787% |
Sage Therapeutics Inc. | 7 | 4 | 0 | 0 | €9.82 | €26.21 | 166.964% |
Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.30 | - | - |